alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with Schizophrenia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borison, R; Gewirtz, GR; Gorman, JM; Gribkoff, G; Macaluso, J; Taylor, DP; Volavka, J | 1 |
Monnet, FP | 1 |
Andreas, J; Benkert, O; Eissner, D; Gründer, G; Heydari, N; Müller, MJ; Nickel, O; Schlegel, S; Schlösser, R; Wetzel, H | 1 |
Akiyama, K; Kanzaki, A; Okumura, K; Otsuki, S; Ujike, H | 1 |
Largent, BL; Snyder, SH | 1 |
2 review(s) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and Schizophrenia
Article | Year |
---|---|
[Involvement of sigma receptors in schizophrenic syndromes. Pathophysiological approach].
Topics: Antipsychotic Agents; Carbazoles; Hippocampus; Humans; Piperidines; Psychotropic Drugs; Pyrimidines; Receptors, sigma; Remoxipride; Schizophrenia; Thalamus | 1993 |
Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.
Topics: Antipsychotic Agents; Benzamides; Carbazoles; Carbolines; Drug Design; Female; Humans; Isoquinolines; Male; Piperazines; Pyridines; Pyrimidines; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, Serotonin; Receptors, sigma; Remoxipride; Schizophrenia; Spiro Compounds | 1989 |
1 trial(s) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and Schizophrenia
Article | Year |
---|---|
BMY 14802, a sigma receptor ligand for the treatment of schizophrenia.
Topics: Adult; Anti-Anxiety Agents; Basal Ganglia Diseases; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pyrimidines; Receptors, sigma; Schizophrenia; Schizophrenic Psychology; Single-Blind Method | 1994 |
2 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and Schizophrenia
Article | Year |
---|---|
Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzamides; Blood-Brain Barrier; Corpus Striatum; Female; Humans; Male; Middle Aged; Oxazoles; Piperidines; Pyrimidines; Pyrrolidines; Receptors, Dopamine D2; Receptors, sigma; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1999 |
Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization.
Topics: Animals; Male; Methamphetamine; Motor Activity; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Schizophrenia; Stereotyped Behavior | 1992 |